Kuala lumpur: DataVault AI, Inc. ('DataVault') and Wellgistics Health, Inc. ('Wellgistics'), both listed on NASDAQ, have announced a strategic collaboration to implement a blockchain-enabled smart contract system, named 'PharmacyChainS', in the prescription drug industry. This initiative aims to enhance efficiency and patient outcomes by digitizing the entire process from prescription to fulfillment.

According to BERNAMA News Agency, the partnership involves a non-binding letter of intent between the two companies. DataVault, known for its expertise in AI data experience, and Wellgistics, a pioneer in pharmaceutical distribution and digital prescription routing, will integrate this smart contract system into Wellgistics' existing technology and infrastructure. The collaboration is expected to streamline the process of ensuring the correct medication reaches patients with appropriate recommendations for safe and effective use.

Nathaniel Bradley, CEO and Co-founder of DataVault AI, highlighted that the U.S. prescription drug market, valued at $634 billion, is on the cusp of a digital transformation. The PharmacyChainS platform is designed to add value to all stakeholders, including manufacturers, physicians, pharmacies, payers, and patients. By leveraging blockchain technology, the initiative promises to create a more efficient, transparent, and accountable prescription ecosystem, aligning financial incentives with improved patient outcomes.